IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Breast cancer subtypes and survival in Chinese women with operable primary breast cancer
Li, Zhao-sheng1; Yao, Lu1; Liu, Yi-qiang2; Ouyang, Tao1; Li, Jin-feng1; Wang, Tian-feng1; Fan, Zhao-qing1; Fan, Tie1; Lin, Ben-Yao1; Xie, Yun-tao1
关键词Breast cancer Subtypes Disease-free survival Overall survival
刊名CHINESE JOURNAL OF CANCER RESEARCH
2011-06-01
DOI10.1007/s11670-011-0134-z
23期:2页:134-139
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]MOLECULAR SUBTYPES ; EXPRESSION ; HER-2
英文摘要

To investigate the associations between the different breast cancer subtypes and survival in Chinese women with operable primary breast cancer.

A total of 1538 Chinese women with operable primary breast cancer were analyzed in this study, the median follow-up was 77 months. Estrogen receptor (ER), progesterone receptor (PR), and HER2 status were available for these patients.

Luminal A (ER+ and/or PR+, HER2-) had a favorable disease-free survival (DFS) and overall survival (OS) compared with other subtypes in the entire cohort. Using the luminal A as a reference, among the patients with lymph node positive disease, HER2+ (ER-, PR-, HER2+) had the worst DFS (hazard ratio, HR=1.80, 95% CI 1.11 to 2.91, P=0.017) and luminal B (ER+ and/or PR+, HER2+) had the worst OS (HR=2.27, 95% CI 1.50 to 3.45, P < 0.001); among the patients with lymph node negative disease, triple-negative (ER-, PR-, HER2-) had the worst DFS (HR=2.21, 95% CI 1.43 to 3.41, P < 0.001), whereas no significant difference in DFS between HER2+ and luminal B or luminal A was observed.

As compared with luminal A, luminal B and HER2+ have the worst survival in patients with lymph node positive disease, but this is not the case in patients with lymph node negative disease; triple-negative subtype has a worse survival in both lymph node positive and lymph node negative patients.

语种英语
WOS记录号WOS:000290804600009
项目编号30973436
资助机构Program fro Breast Cancer Tissue Bank of Beijing ; National Natural Science Foundation of China
引用统计
被引频次:7[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/60863
专题北京大学临床肿瘤学院
北京大学临床肿瘤学院_乳腺癌预防治疗中心
北京大学临床肿瘤学院_病理科
北京大学临床肿瘤学院_乳腺中心实验室
作者单位1.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst,Breast Ctr, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China
2.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst,Dept Pathol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China
推荐引用方式
GB/T 7714
Li, Zhao-sheng,Yao, Lu,Liu, Yi-qiang,et al. Breast cancer subtypes and survival in Chinese women with operable primary breast cancer[J]. CHINESE JOURNAL OF CANCER RESEARCH,2011,23(2):134-139.
APA Li, Zhao-sheng.,Yao, Lu.,Liu, Yi-qiang.,Ouyang, Tao.,Li, Jin-feng.,...&Xie, Yun-tao.(2011).Breast cancer subtypes and survival in Chinese women with operable primary breast cancer.CHINESE JOURNAL OF CANCER RESEARCH,23(2),134-139.
MLA Li, Zhao-sheng,et al."Breast cancer subtypes and survival in Chinese women with operable primary breast cancer".CHINESE JOURNAL OF CANCER RESEARCH 23.2(2011):134-139.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, Zhao-sheng]的文章
[Yao, Lu]的文章
[Liu, Yi-qiang]的文章
百度学术
百度学术中相似的文章
[Li, Zhao-sheng]的文章
[Yao, Lu]的文章
[Liu, Yi-qiang]的文章
必应学术
必应学术中相似的文章
[Li, Zhao-sheng]的文章
[Yao, Lu]的文章
[Liu, Yi-qiang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。